Vincent Vultaggio Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Vincent Vultaggio is PAO and Interim PFO of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 189,826 shares of ZNTL, which is worth approximately $364,465. The most recent transaction as insider was on Feb 03, 2025, when has been sold 2,615 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $4,471. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 190K
460.7% 3M change
n/a 12M change
Total Value Held $364,465

Vincent Vultaggio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$4,471 $1.71 p/Share
2,615 Reduced 1.36%
189,826 Common Stock
Feb 03 2025
BUY
Grant, award, or other acquisition
-
158,586 Added 45.18%
192,441 Common Stock
Oct 04 2024
SELL
Open market or private sale
$5,097 $3.18 p/Share
1,603 Reduced 4.52%
33,855 Common Stock
VV

Vincent Vultaggio

PAO and Interim PFO
San Diego, CA

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL